DSM-5-TR: overview of what's new and what's changed.
作者信息
First Michael B, Yousif Lamyaa H, Clarke Diana E, Wang Philip S, Gogtay Nitin, Appelbaum Paul S
机构信息
Department of Psychiatry, Columbia University, New York, NY, USA.
American Psychiatric Association, Washington, DC, USA.
出版信息
World Psychiatry. 2022 Jun;21(2):218-219. doi: 10.1002/wps.20989.
Abstract
摘要
相似文献
1
DSM-5-TR: overview of what's new and what's changed.《精神疾病诊断与统计手册》第五版修订版（DSM-5-TR）：新增内容与变化概述。
World Psychiatry. 2022 Jun;21(2):218-219. doi: 10.1002/wps.20989.
2
Future Hospital Commission - 10 years on. What's changed, what's new and what's next?未来医院委员会——十年之后。有哪些变化、有哪些新情况以及接下来会怎样？
Future Healthc J. 2024 Jul 12;11(2):100155. doi: 10.1016/j.fhj.2024.100155. eCollection 2024 Jun.
3
Small animal dermatopathology: 'what's old, what's new, what's borrowed, what's useful'.小动物皮肤病理学：“旧闻、新闻、借鉴、实用”。
Semin Vet Med Surg Small Anim. 1987 Aug;2(3):162-5.
4
A commentary on the evolution of NIH: what's in, what's out, what's hot, what's not.关于美国国立卫生研究院发展历程的述评：哪些入选，哪些落选，哪些热门，哪些冷门。
Integr Physiol Behav Sci. 1998 Apr-Jun;33(2):115-7. doi: 10.1007/BF02688652.
5
Cardiovascular product update and evaluation. What's hot, what's not, what's in, what's out.心血管产品更新与评估。热门产品、冷门产品、流行产品、淘汰产品。
J Interv Cardiol. 1994 Apr;7(2):203-4. doi: 10.1111/j.1540-8183.1994.tb00905.x.
6
Cardiovascular product update and evaluation. What's hot, what's not, what's in, what's out.心血管产品更新与评估。热门产品、冷门产品、流行产品、淘汰产品。
J Interv Cardiol. 1992 Mar;5(1):67-8. doi: 10.1111/j.1540-8183.1992.tb00827.x.
7
The Editor's Workshop: Pediatric and adolescent gynecology: What's the issue? What's the answer? What's the big picture? What's the national perspective?编辑工作室：儿科与青少年妇科：问题是什么？答案是什么？全局情况如何？全国视角怎样？
J Pediatr Adolesc Gynecol. 2009 Aug;22(4):195-6. doi: 10.1016/j.jpag.2009.06.001.
8
Dermatologic therapy--1960. What's new? and what's true of what's new?皮肤病治疗——1960年。有哪些新进展？新进展中哪些是真实可靠的？
Acta Derm Venereol. 1961;41:187-93.
9
What's new and what's true of what's new in dermatology.皮肤病学领域的新进展以及这些新进展的真实性。
Calif Med. 1955 Jul;83(1):1-5.
10
Binge eating disorder revisited: what's new, what's different, what's next - Addendum.暴饮暴食症再探讨：新变化、差异及未来走向——附录
CNS Spectr. 2019 Aug;24(S1):82. doi: 10.1017/S1092852919001366.
引用本文的文献
1
The damaging legacy of damage-centered LGBTIQ+ research: Implications for healthcare and LGBTIQ+ health.以伤害为中心的LGBTIQ+研究的有害遗产：对医疗保健和LGBTIQ+健康的影响。
J Soc Issues. 2024 Sep;80(3):973-999. doi: 10.1111/josi.12641. Epub 2024 Oct 8.
2
The Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TSC) in Community Mental Health: Evaluating Self-Reported Psychiatric Disorders as a Predictor of Symptoms and Treatment Outcome.社区心理健康中睡眠与昼夜节律功能障碍的跨诊断干预（TSC）：评估自我报告的精神障碍作为症状和治疗结果的预测指标。
Res Sq. 2025 Aug 6:rs.3.rs-7189279. doi: 10.21203/rs.3.rs-7189279/v1.
3
Global burden on drug use disorders from 1990 to 2021 and projections to 2046.1990年至2021年药物使用障碍的全球负担及到2046年的预测。
Front Public Health. 2025 Jul 28;13:1550518. doi: 10.3389/fpubh.2025.1550518. eCollection 2025.
4
Comparative efficacy of psychological interventions for internet gaming disorder: a meta-analysis of randomized controlled trials.网络成瘾障碍心理干预的比较疗效：随机对照试验的荟萃分析
Front Psychiatry. 2025 Jul 10;16:1619138. doi: 10.3389/fpsyt.2025.1619138. eCollection 2025.
5
A Comprehensive Review on Plant-Based Medications and Chemical Approaches for Autism Spectrum Disorders (ASDs) Psychopharmacotherapy.关于自闭症谱系障碍（ASD）心理药物治疗的植物性药物和化学方法的综合综述。
Indian J Microbiol. 2025 Mar;65(1):15-31. doi: 10.1007/s12088-024-01265-y. Epub 2024 Apr 10.
6
Cannabichromene, a key non-psychotropic phytocannabinoid in treatment of major depressive disorder: in silico and in vivo explorations.大麻二酚，一种治疗重度抑郁症的关键非精神活性植物大麻素：计算机模拟和体内实验探索
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 13. doi: 10.1007/s00210-025-04236-2.
7
Case Report: The intersection of psychiatry and medicine: diagnostic and ethical insights from case studies.病例报告：精神病学与医学的交叉领域：来自案例研究的诊断与伦理见解
Front Psychiatry. 2025 Apr 22;16:1576179. doi: 10.3389/fpsyt.2025.1576179. eCollection 2025.
8
The Role of Empathy in ADHD Children: Neuropsychological Assessment and Possible Rehabilitation Suggestions-A Narrative Review.同理心在多动症儿童中的作用：神经心理学评估及可能的康复建议——一项叙述性综述
Medicina (Kaunas). 2025 Mar 15;61(3):505. doi: 10.3390/medicina61030505.
9
Reevaluating ADHD and its First-Line Treatment: Insights from DSM-5-TR and Modern Approaches.重新评估注意力缺陷多动障碍及其一线治疗：来自《精神疾病诊断与统计手册》第5版修订版及现代方法的见解
Clin Neuropsychiatry. 2024 Oct;21(5):436-443. doi: 10.36131/cnfioritieditore20240507.
10
The comparison of efficacy of Escitalopram and Bupropion in treatment of depression symptoms in patients with heart failure: randomized clinical trial.艾司西酞普兰与安非他酮治疗心力衰竭患者抑郁症状的疗效比较：随机临床试验
Ann Med Surg (Lond). 2024 Sep 17;86(11):6546-6554. doi: 10.1097/MS9.0000000000002574. eCollection 2024 Nov.
本文引用的文献
1
Prolonged Grief Disorder: Course, Diagnosis, Assessment, and Treatment.持续性悲伤障碍：病程、诊断、评估与治疗
Focus (Am Psychiatr Publ). 2021 Jun;19(2):161-172. doi: 10.1176/appi.focus.20200052. Epub 2021 Jun 17.
2
Iterative Revision of the : An Interim Report From the Steering Committee.迭代修订的：指导委员会的临时报告。
Psychiatr Serv. 2021 Nov 1;72(11):1348-1349. doi: 10.1176/appi.ps.202100013. Epub 2021 Apr 22.
3
Validation of the new DSM-5-TR criteria for prolonged grief disorder and the PG-13-Revised (PG-13-R) scale.新的《精神疾病诊断与统计手册》第五版修订版（DSM-5-TR）中持续性悲伤障碍标准及PG-13修订版（PG-13-R）量表的验证
World Psychiatry. 2021 Feb;20(1):96-106. doi: 10.1002/wps.20823.
4
Adopting a continuous improvement model for future DSM revisions.为未来的精神疾病诊断与统计手册（DSM）修订采用持续改进模型。
World Psychiatry. 2016 Oct;15(3):223-224. doi: 10.1002/wps.20342.
5
Characterizing the cognitive effects of cocaine: a comprehensive review.描述可卡因的认知效应：全面综述。
Neurosci Biobehav Rev. 2013 Sep;37(8):1838-59. doi: 10.1016/j.neubiorev.2013.07.003. Epub 2013 Jul 20.
6
The DSM-IV Text Revision: rationale and potential impact on clinical practice.《精神疾病诊断与统计手册》第四版修订版：原理及对临床实践的潜在影响。
Psychiatr Serv. 2002 Mar;53(3):288-92. doi: 10.1176/appi.ps.53.3.288.
Zotero 插件